What question did this study set out to answer?

This research aims to explore targeted inhibition of DNA methyltransferases to enhance glioblastoma multiforme cell sensitivity to temozolomide.

June 13, 2026RSC Medicinal Chemistry

From AlphaFold to site-selective inhibition of DNA methylation in glioblastoma multiforme

View Full Paper

Ask AI

Bookmark

Authors

JBJean-Maxime Besson ACAlain Chavanieu ANArulraj Nadaradjane

Discussion

Member takes

Overview

Randomized trial targets DNA methyltransferases to improve response to temozolomide in glioblastoma multiforme, indicating potential for enhanced treatment outcomes.

Key Points

This research aims to explore targeted inhibition of DNA methyltransferases to enhance glioblastoma multiforme cell sensitivity to temozolomide.
Targeted protein-protein interactions were examined using advanced computational tools such as AlphaFold.
Specific inhibitors were developed to selectively inhibit DNA methyltransferases in vitro.
The study involved testing these inhibitors on glioblastoma multiforme cell lines.
The use of site-selective inhibitors led to a significant resensitization of glioblastoma multiforme cells to temozolomide treatment.
Inhibited cells showed reduced DNA methylation levels, correlating with improved drug efficacy.

Cite This Study

Besson et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf4aefaef96ed7f056d96 https://doi.org/10.1039/d5md00988j

View Full Paper

Ask AI

Bookmark

June 13, 2026RSC Medicinal Chemistry

From AlphaFold to site-selective inhibition of DNA methylation in glioblastoma multiforme

View Full Paper

Ask AI

Bookmark

Authors

JBJean-Maxime Besson ACAlain Chavanieu ANArulraj Nadaradjane

Discussion

Member takes

Overview

Randomized trial targets DNA methyltransferases to improve response to temozolomide in glioblastoma multiforme, indicating potential for enhanced treatment outcomes.

Key Points

This research aims to explore targeted inhibition of DNA methyltransferases to enhance glioblastoma multiforme cell sensitivity to temozolomide.
Targeted protein-protein interactions were examined using advanced computational tools such as AlphaFold.
Specific inhibitors were developed to selectively inhibit DNA methyltransferases in vitro.
The study involved testing these inhibitors on glioblastoma multiforme cell lines.
The use of site-selective inhibitors led to a significant resensitization of glioblastoma multiforme cells to temozolomide treatment.
Inhibited cells showed reduced DNA methylation levels, correlating with improved drug efficacy.

Cite This Study

Besson et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf4aefaef96ed7f056d96 https://doi.org/10.1039/d5md00988j

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark